Growth Hormone Gene Deletion
Drug | Drug Name | Drug Description |
---|---|---|
DB14751 | Mecasermin rinfabate | Mecasermin rinfabate was approved for treatment of severe primary insulin-like growth factor (IGF) deficiency or in patients with GH gene deletion who have developed antibodies to growth hormone (GH) .... |
Drug | Drug Name | Phase | Status | Count |
---|